Page 128 - 南京医科大学学报自然科学版

第43卷第9期
·1306 · 南 京 医 科 大 学 学 报 2023年9月

333 （EBC）［J］.Ann Oncol，2013，24（8）：1986-1993
［36］ ULANER G A，JHAVERI K，CHANDARLAPATY S，et ［44］ LEE S I，CATALANO O A，DEHDASHTI F. Evaluation of
18
18
18
al. Head⁃to⁃head evaluation of F⁃FES and F⁃FDG PET/ gynecologic cancer with MR imaging，F⁃FDG PET/CT，
CT in metastatic invasive lobular breast cancer［J］. J Nucl and PET/MR imaging［J］. J Nucl Med，2015，56（3）：436-
Med，2021，62（3）：326-331 443
［37］ VAN KRUCHTEN M，DE VRIES E F，ARTS H J，et al. ［45］ GONG J，WANG N，BIAN L H，et al. Cervical cancer evalu⁃
18
Assessment of estrogen receptor expression in epithelial ated with integrated F ⁃ FDG PET/MR［J］. Oncol Lett，
18
ovarian cancer patients using 16α⁃ F⁃fluoro⁃17β⁃estradiol 2019，18（2）：1815-1823
PET/CT［J］. J Nucl Med，2015，56（1）：50-55 ［46］SCHWARTZ M，GAVANE S C，BOU⁃AYACHE J，et al.
［38］ YAMADA S，TSUYOSHI H，YAMAMOTO M，et al. Prog⁃ Feasibility and diagnostic performance of hybrid PET/
18
nostic value of 16α⁃ F⁃fluoro⁃17β⁃estradiol PET as a pre⁃ MRI compared with PET/CT for gynecological malignan⁃
dictor of disease outcome in endometrial cancer：a pro⁃ cies：a prospective pilot study［J］. Abdom Radiol，2018，
spective study［J］. J Nucl Med，2021，62（5）：636-642 43（12）：3462-3467
［39］ TSUJIKAWA T，YOSHIDA Y，KUDO T，et al. Functional ［47］ BRENT R L. Saving lives and changing family histories：
images reflect aggressiveness of endometrial carcinoma： appropriate counseling of pregnant women and men and
18
estrogen receptor expression combined with F⁃FDG PET women of reproductive age，concerning the risk of diagnos⁃
［J］. J Nucl Med，2009，50（10）：1598-1604 tic radiation exposures during and before pregnancy［J］.
［40］ GOUGELET A，MUELLER S O，KORACH K S，et al. Oes⁃ Am J Obstet Gynecol，2009，200（1）：4-24
trogen receptors pathways to oestrogen responsive ele⁃ ［48］ SELMAN T J，MANN C，ZAMORA J，et al. Diagnostic ac⁃
ments：the transactivation function⁃1 acts as the keystone curacy of tests for lymph node status in primary cervical
of oestrogen receptor（ER）beta ⁃ mediated transcriptional cancer：a systematic review and meta⁃analysis［J］. CMAJ，
repression of ERalpha［J］. J Steroid Biochem Mol Biol， 2008，178（7）：855-862
2007，104（3/4/5）：110-122 ［49］ ISHIGURO T，NISHIKAWA N，ISHII S，et al. PET/MR
［41］ ANTUNES I F，VAN WAARDE A，DIERCKX R A，et al. imaging for the evaluation of cervical cancer during preg⁃
Synthesis and evaluation of the estrogen receptor β⁃selec⁃ nancy［J］. BMC Pregnancy Childbirth，2021，21（1）：288
18
18
tive radioligand 2⁃ F⁃fluoro⁃6⁃（6⁃hydroxynaphthalen⁃2⁃ ［50］ SPICK C，HERRMANN K，CZERNIN J. F⁃FDG PET/CT
18
yl）pyridin⁃3⁃ol：comparison with 16α⁃ F⁃fluoro⁃17β⁃es⁃ and PET/MRI perform equally wellin cancer：evidence
tradiol［J］. J Nucl Med，2017，58（4）：554-559 from studieson more than 2，300 patients［J］. J Nucl Med，
［42］ ANTUNES I F，WILLEMSEN A T M，SIJBESMA J W A， 2016，57（3）：420-430
et al. In vivo quantification of ERβ expression by pharma⁃ ［51］ SAWICKI L M，KIRCHNER J，GRUENEISEN J，et al.
18 18
cokinetic modeling：studies with F⁃FHNP PET［J］. J Nu⁃ Comparison of F ⁃ FDG PET/MRI and MRI alone for
cl Med，2017，58（11）：1743-1748 whole ⁃ body staging and potential impact on therapeutic
［43］ YAN Y，LI X，BLANCHARD A，et al. Expression of both management of women with suspected recurrent pelvic
estrogen receptor⁃beta 1（ER⁃β1）and its co⁃regulator ste⁃ cancer：a follow⁃up study［J］. Eur J Nucl Med Mol Imag，
roid receptor RNA activator protein（SRAP）are predictive 2018，45（4）：622-629
for benefit from tamoxifen therapy in patients with estro⁃ ［收稿日期］ 2023-05-17
gen receptor⁃alpha（ER⁃α）⁃negative early breast cancer （本文编辑：陈汐敏）